563 related articles for article (PubMed ID: 2998603)
21. Regarding: Valero V, Buzdar AU, Hortobagyi GN. "Locally Advanced Breast Cancer," The Oncologist 1996;1:8-17.
Oliver RT
Oncologist; 1996; 1(4):278-279. PubMed ID: 10388003
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy and cancer of the gastrointestinal tract.
Terz JJ; Beatty JD
Surg Annu; 1979; 11():149-80. PubMed ID: 388686
[TBL] [Abstract][Full Text] [Related]
23. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
24. Relevance of high-dose chemotherapy in solid tumours.
Nieboer P; de Vries EG; Mulder NH; van der Graaf WT
Cancer Treat Rev; 2005 May; 31(3):210-25. PubMed ID: 15944050
[TBL] [Abstract][Full Text] [Related]
25. The role of chemotherapy in the treatment of small cell lung cancer.
Shepherd FA
Chest Surg Clin N Am; 1997 Feb; 7(1):113-33. PubMed ID: 9001760
[TBL] [Abstract][Full Text] [Related]
26. [Progress in the chemotherapy of malignant tumors].
Cavalli F
Ther Umsch; 1985 Aug; 42(8):541-6. PubMed ID: 3863258
[No Abstract] [Full Text] [Related]
27. The use of drugs in combination for the treatment of cancer: rationale and results.
DeVita VT; Schein PS
N Engl J Med; 1973 May; 288(19):998-1006. PubMed ID: 4348752
[No Abstract] [Full Text] [Related]
28. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
[TBL] [Abstract][Full Text] [Related]
29. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
30. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
Glanzmann C; Veraguth A; Lütolf UM
Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
[TBL] [Abstract][Full Text] [Related]
31. [High-dose methotrexate with citrovorum factor rescue (HD-MTX-CFR) in the treatment of malignant solid tumors--clinical analysis of 62 patients].
Wang QL; Sun Y; Zhou JC; Song SZ; Feng FY; Lu L; Yie ZS
Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):152-4. PubMed ID: 3264785
[TBL] [Abstract][Full Text] [Related]
32. Advances in the management of epithelial ovarian cancer.
Berkenblit A; Cannistra SA
J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
[TBL] [Abstract][Full Text] [Related]
33. [High-dose chemotherapy with hematopoietic salvage in patients with breast cancer].
Perey L; Leyvraz S
Praxis (Bern 1994); 1995 Mar; 84(9):259-63. PubMed ID: 7892554
[TBL] [Abstract][Full Text] [Related]
34. [The role of autologous bone marrow transplantation in cancer treatment].
Harada M
Gan To Kagaku Ryoho; 1987 Nov; 14(11):2989-97. PubMed ID: 2823720
[TBL] [Abstract][Full Text] [Related]
35. Effective adjuvant treatments. A brief review of U.S. clinical trials.
Louie AC; Rozencweig M; von Hoff DD; Muggia FM
Arch Geschwulstforsch; 1978; 48(7):653-8. PubMed ID: 282826
[TBL] [Abstract][Full Text] [Related]
36. New developments in clinical oncology: the interdependence of bench and bedside.
Antman KH
Cancer Res; 1991 Sep; 51(18 Suppl):5060s-5064s. PubMed ID: 1679375
[TBL] [Abstract][Full Text] [Related]
37. [A new combination of methotrexate and folinic acid for cancer treatment (acute leukemia and solid tumors)].
Schwarzenberg L; Mathé G; Hayat M; de Vassal F; Amiel JL; Cattan A; Schneider M; Schlumberger JR; Rosenfeld C; Jasmin C; Ngo Minh Man
Presse Med (1893); 1969 Mar; 77(11):385-8. PubMed ID: 4891646
[No Abstract] [Full Text] [Related]
38. Current trends and prospects in surgical adjuvant trials.
Rozencweig M; von Hoff DD; Louie AC; Muggia FM
Arch Geschwulstforsch; 1978; 48(7):673-9. PubMed ID: 282827
[TBL] [Abstract][Full Text] [Related]
39. Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms.
Lissoni P; Barni S; Tancini G; Viviani S; Rovelli F; Rescaldani R; Fiorelli G
J Biol Regul Homeost Agents; 1989; 3(3):131-3. PubMed ID: 2560317
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and pharmacodynamics of anticancer agents: contributions to the therapy of childhood cancer.
Petros WP; Evans WE
Pharmacotherapy; 1990; 10(5):313-25. PubMed ID: 2235668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
